J R Michael1, R G Barton, J R Saffle
1Department of Medicine, University of Utah School of Medicine, Salt Lake City, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Inhaled nitric oxide (iNO) offers a temporary oxygenation boost for acute respiratory distress syndrome (ARDS) patients. However, it does not provide sustained benefits compared to conventional therapy over 72 hours.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: